188 related articles for article (PubMed ID: 8960139)
1. Overexpression and amplification of c-myc during progression of human colorectal cancer.
Rochlitz CF; Herrmann R; de Kant E
Oncology; 1996; 53(6):448-54. PubMed ID: 8960139
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
4. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
Kawate S; Fukusato T; Ohwada S; Watanuki A; Morishita Y
Oncology; 1999; 57(2):157-63. PubMed ID: 10461064
[TBL] [Abstract][Full Text] [Related]
5. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
Sauter G; Carroll P; Moch H; Kallioniemi A; Kerschmann R; Narayan P; Mihatsch MJ; Waldman FM
Am J Pathol; 1995 May; 146(5):1131-9. PubMed ID: 7747807
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas.
Wu R; Lin L; Beer DG; Ellenson LH; Lamb BJ; Rouillard JM; Kuick R; Hanash S; Schwartz DR; Fearon ER; Cho KR
Am J Pathol; 2003 May; 162(5):1603-10. PubMed ID: 12707044
[TBL] [Abstract][Full Text] [Related]
7. Over-expression and amplification of the c-myc gene in human urothelial carcinoma.
Christoph F; Schmidt B; Schmitz-Dräger BJ; Schulz WA
Int J Cancer; 1999 Apr; 84(2):169-73. PubMed ID: 10096250
[TBL] [Abstract][Full Text] [Related]
8. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
Singhi AD; Cimino-Mathews A; Jenkins RB; Lan F; Fink SR; Nassar H; Vang R; Fetting JH; Hicks J; Sukumar S; De Marzo AM; Argani P
Mod Pathol; 2012 Mar; 25(3):378-87. PubMed ID: 22056952
[TBL] [Abstract][Full Text] [Related]
9. Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.
Blancato J; Singh B; Liu A; Liao DJ; Dickson RB
Br J Cancer; 2004 Apr; 90(8):1612-9. PubMed ID: 15083194
[TBL] [Abstract][Full Text] [Related]
10. Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.
Masramon L; Arribas R; Tórtola S; Perucho M; Peinado MA
Br J Cancer; 1998 Jun; 77(12):2349-56. PubMed ID: 9649157
[TBL] [Abstract][Full Text] [Related]
11. Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene.
Heerdt BG; Molinas S; Deitch D; Augenlicht LH
Oncogene; 1991 Jan; 6(1):125-9. PubMed ID: 1992440
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
Smith DR; Myint T; Goh HS
Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between DNA copy number and mRNA expression levels of c-myc in gamma-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR.
Santos J; Vaquero C; Reyes J; López-Nieva P; Matabuena M; Villa M; Fernández P; Fernández-Piqueras J
Clin Transl Oncol; 2006 May; 8(5):349-53. PubMed ID: 16760010
[TBL] [Abstract][Full Text] [Related]
16. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
17. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis.
Watson PH; Safneck JR; Le K; Dubik D; Shiu RP
J Natl Cancer Inst; 1993 Jun; 85(11):902-7. PubMed ID: 8492318
[TBL] [Abstract][Full Text] [Related]
18. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z
Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastases.
Rochlitz CF; Heide I; Thiede C; Herrmann R; de Kant E
Ann Oncol; 1995 Dec; 6(10):981-6. PubMed ID: 8750149
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics.
Obara K; Yokoyama M; Asano G; Tanaka S
Int J Oncol; 2001 Feb; 18(2):233-9. PubMed ID: 11172587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
